Hydrophobic sodium fluoride-based nanocrystals doped with lanthanide ions: Assessment of in vitro toxicity to human blood lymphocytes and phagocytes

Journal of Applied Toxicology

Volumn 34, Issue 11, 2014, Pages 1220-1225

  Sojka, Bartlomiej ^a   Kuricova, Miroslava ^b   Liskova, Aurelia ^b   Bartusova, Maria ^b   Banski, Mateusz ^a   Misiewicz, Jan ^a   Dusinska, Maria ^c   Horvathova, Mira ^b   Jahnova, Eva ^b   Ilavska, Silvia ^b   Szabova, Michaela ^b   Rollerova, Eva ^b   Podhorodecki, Artur ^a   Tulinska, Jana ^b  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^c NORWEGIAN INSTITUTE FOR AIR RESEARCH   (Norway)

Author keywords

Human peripheral blood lymphocytes; Hydrophobic; in vitro toxicity; Nanocrystals; Phagocytes; Sodium fluoride based nanocrystals doped with lanthanide ions

Indexed keywords

LANTHANIDE; MITOGENIC AGENT; NANOPARTICLE; PHYTOHEMAGGLUTININ; SODIUM FLUORIDE;

ADULT; B LYMPHOCYTE; CELL PROLIFERATION; CHEMICAL PHENOMENA; DRUG EFFECTS; FEMALE; HUMAN; MIDDLE AGED; PHAGOCYTE; T LYMPHOCYTE;

ADULT; B-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LANTHANOID SERIES ELEMENTS; MIDDLE AGED; MITOGENS; NANOPARTICLES; PHAGOCYTES; PHYTOHEMAGGLUTININS; SODIUM FLUORIDE; T-LYMPHOCYTES;

EID: 84907817971     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.3050     Document Type: Article

References (38)

1. Azzi J, Tang L, Moore R, Tong R, El Haddad N, Akiyoshi T, Mfarrej B, Yang S, Jurewicz M, Ichimura T, Lindeman N, Cheng J, Abdi R. 2010. Polylactide-cyclosporin A nanoparticles for targeted immunosuppression. FASEB J. 24: 3927-3938.
2. Banski M, Podhorodecki A, Misiewicz J. 2013. NaYF4 nanocrystals with TOPO ligands: synthesis-dependent structural and luminescent properties. Phys. Chem. Chem. Phys. 15: 19232-19241.
3. Banski M, Podhorodecki A, Misiewicz J, Afzaal M, O Brien P. 2013. Selective excitation of Eu3+in the core of small b-NaGdF4nanocrystals. J. Mater. Chem. C. 1: 801-807.
4. Chen G, Chen W, Wu Z, Yuan R, Li H, Gao J, Shuai X. 2009. MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression. Biomaterials 30: 1962-1970.
5. Cheng L, Yang K, Shao M, Lee ST, Liu Z. 2011. Multicolor In Vivo Imaging of Upconversion Nanoparticles with Emissions Tuned by Luminescence Resonance Energy Transfer. J. Phys. Chem. C 115: 2686-2692.
6. Cohen JM, Teeguarden JG, Demokritou P. 2014. An integrated approach for the in vitro dosimetry of engineered Nanomaterials. Part. Fibre Toxicol. 11: 20.
7. Ducongé F, Pons T, Pestourie C, Hérin L, Thézé B, Gombert K, Mahler B, Hinnen, F, Kühnast B, Dollé F, Dubertret B, Tavitian B, 2008. Fluorine-18-Labeled Phospholipid Quantum Dot Micelles for in Vivo Multimodal Imaging from Whole Body to Cellular Scales. Bioconjugate Chem. 19: 1921-1926.
8. Gangwal S, Brown JS, Wang A, Houck KA, Dix DJ, Kavlock RJ, Laine A, Cohen Hubal EAC. 2011. Informing Selection of Nanomaterial Concentrations for ToxCast in Vitro Testing Based on Occupational Exposure Potential. Environ. Health Perspect. 11: 1539-1546. DOI: 10.1289/ehp.1103750
9. Gao J, Chen K, Xie R, Xie J, Yan Y, Cheng Z, Peng X, Chen, X. 2010. In Vivo Tumor-Targeted Fluorescence Imaging Using Near-Infrared Non-Cadmium Quantum Dots. Bioconjugate Chem. 21: 604-609.
10. Idris NM, Li Z, Ye L, Sim EK, Mahendran R, Ho PC, Zhang Y. 2009. Tracking transplanted cells in live animal using upconversion fluorescent nanoparticles. Biomaterials 30: 5104-5113.
11. Jalil Abdul R, Zhang Y. 2008. Biocompatibility of silica coated NaYF(4) upconversion fluorescent nanocrystals. Biomaterials 29: 4122-4128. DOI: 10.1016/j.biomaterials.2008.07.012
12. 3+upconversion nanoparticles for charge-dependent cellular imaging. ACS Nano 5: 7838-7847.
13. Kennedy IM, Wilson D, Barakat AI. 2009. HEI Health Review Committee. Uptake and inflammatory effects of nanoparticles in a human vascular endothelial cell line. Res. Rep. Health Eff. Inst. 136: 3-32.
14. Kim JW, Galanzha EI, Zaharoff DA, Griffin RJ, Zharov VP. 2013. Nanotheranostics of Circulating Tumor Cells, Infections and Other Pathological Features in Vivo. Mol. Pharmaceutics 10: 813-830.
15. Kumar R, Ding H, Hu R, Yong KT, Roy I, Bergey EJ, Prasad PN. 2010. In vitro and In vivo Optical Imaging Using Water-Dispersible, Noncytotoxic, Luminescent, Silica-Coated Quantum Rods. Chem. Mater. 22: 2261-2267.
16. Lellouche J, Friedman A, Gedanken A, Banin E. 2012. Antibacterial and antibiofilm properties of yttrium fluoride nanoparticles. Int. J. Nanomedicine 7: 5611-5624.
17. Look M, Stern E, Wang QA, DiPlacido LD, Kashgarian M, Craft J, Fahmy TM. 2013. Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice. J. Clin. Invest. 123: 1741-1749.
18. Ma G. 2013. Background-Free In vivo Time Domain Optical Molecular Imaging Using Colloidal Quantum Dots. ACS Appl. Mater. Interfaces 5: 2835-2844.
19. Magdolenova Z, Drlickova M, Henjum K, Runden-Pran E, Tulinska J, Bilanicova D, Pojana G, Kazimirova A, Barancokova M, Kuricova M, Liskova A, Staruchova M, Ciampor F, Vavra I, Lorenzo Y, Collins A, Rinna A, Fjellsbø L, Volkovova K, Marcomini A, Amiry-Moghaddam M, Dusinska M. 2013. Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles. Nanotoxicology. Nov 14. [Epub ahead of print]
20. Maldiney T, Kaikkonen MU, Seguin J, le Masne de Chermont Q, Bessodes M, Airenne KJ, Ylä-Herttuala S, Scherman D, Richard C. 2012. In Vitro Targeting of Avidin-Expressing Glioma Cells with Biotinylated Persistent Luminescence Nanoparticles. Bioconjugate Chem. 23: 472-478.
21. Nyk M, Kuma, R, Ohulchanskyy TY, Bergey EJ, Prasad PN. 2008. High Contrast in Vitro and in Vivo Photoluminescence Bioimaging Using Near Infrared to Near Infrared Up-Conversion in Tm3+ and Yb3+ Doped Fluoride Nanophosphors. Nano Lett. 8: 3834-3838.
22. Park K. 2013. Facing the Truth about Nanotechnology in Drug Delivery. ACS Nano 7: 7442-7447.
23. Podhorodecki A, Banski M, Misiewicz J, Afzaal M, O'Brien P, Cha D, Wang X. 2012. J. Mater. Chem. 22: 5356-5361.
24. Qian XM, Nie SM. 2008. Single-molecule and single-nanoparticle SERS: from fundamental mechanisms to biomedical applications. Chem. Soc. Rev. 37: 912-920.
25. Toyota T, Ohguri N, Maruyama K, Fujinami M, Saga T, Aoki I. 2012. Giant Vesicles Containing Superparamagnetic Iron Oxide as Biodegradable Cell-Tracking MRI Probes. Anal. Chem. 84: 3952-3957.
26. Tulinska J, Kazimirova A, Kuricova M, Barancokova M, Liskova A, Neubauerova E, Drlickova M, Ciampo, F, Vavra I, Bilanicova D, Pojana G, Staruchova M, Horvathova, M, Jahnova E, Volkovova K, Bartusova M, Cagalinec M, Dusinska M. 2013. Immunotoxicity and genotoxicity testing of PLGA-PEO nanoparticles in human blood cell model. Nanotoxicology Jul 17. [Epub ahead of print].
27. Vetrone F, Naccache R, Juarranz de la Fuente A, Sanz-Rodríguez F, Blazquez-Castro A, Rodriguez, EM, Jaque D, Solé JG, Capobianco JA. 2010. Intracellular imaging of HeLa cells by non-functionalized NaYF4:Er3+, Yb3+ upconverting nanoparticles. Nanoscale 2: 495-498.
28. Wang X, Chen JT, Zhu H, Chen X, Yan XP. 2013. One-Step Solvothermal Synthesis of Targetable Optomagnetic Upconversion Nanoparticles for in Vivo Bimodal Imaging. Anal. Chem. 85: 10225-10231.
29. Wei Y, Chen Q, Wu B, Zhou A, Xing D, 2012. High-sensitivity in vivo imaging for tumors using a spectral up-conversion nanoparticle NaYF4: Yb3+, Er3+ in cooperation with a microtubulin inhibitor. Nanoscale 4: 3901-3909.
30. Xia A, Gao Y, Zhou J, Li C, Yang T, Wu D, Wu L, Li F. 2011. Core-shell NaYF4:Yb3+, Tm3+at FexOy nanocrystals for dual-modality T2-enhanced magnetic resonance and NIR-to-NIR upconversion luminescent imaging of small-animal lymphatic node. Biomaterials 32: 7200-7208.
31. Xing H, Bu W, Ren Q, Zheng X, Li M, Zhang S, Qu H, Wang Z, Hua Y, Zhao K, Zhou, L, Peng W, Shi J, 2012. A NaYbF4: Tm3+ nanoprobe for CT and NIR-to-NIR fluorescent bimodal imaging. Biomaterials 33: 5384-5393.
32. Xu G, Yong KT, Roy I, Mahajan SD, Ding H, Schwartz SA, Prasad PN. 2008. Bioconjugated Quantum Rods as Targeted Probes for Efficient Transmigration Across an in Vitro Blood-brain Barrier. Bioconjugate Chem. 19: 1179-1185.
33. Xu QC, Zhang Y, Tan MJ, Liu Y, Yuan S, Choong C, Tan NS, Tan TT. 2012. Anti-cAngptl4 Ab-conjugated N-TiO(2) /NaYF(4): Yb, Tm nanocomposite for near infrared-triggered drug release and enhanced targeted cancer cell ablation. Adv. Healthc. Mater. 1: 470-474.
34. 3+ nanospheres for cell imaging and targeted anti-cancer drug delivery (HeLa, L929). Biomaterials 34: 1601-1612.
35. Yuan P, Lee YH, Gnanasammandhan MK, Guan Z, Zhang Y, Xu QH. 2012. Plasmon enhanced upconversion luminescence of NaYF4:Yb, Er at SiO2 at Ag core-shell nanocomposites for cell imaging. Nanoscale 4: 5132-5137.
36. Zhou JC, Yang ZL, Dong W, Tang RJ, Sun LD, Yan CH. 2011. Bioimaging and toxicity assessments of near-infrared upconversion luminescent NaYF4:Yb, Tm nanocrystals. Biomaterials 32: 9059-9067.
37. Zhu Y, Fang Y, Kaskel S. 2010. Folate-Conjugated Fe3O4 at SiO2 Hollow Mesoporous Spheres for Targeted Anticancer Drug Delivery. J. Phys. Chem. C 114: 16382-16388.
38. Zogovic NS, Nikolic NS, Vranjes-Djuric SD, Harhaji LM, Vucicevic LM, Janjetovic KD, Misirkic MS, Todorovic-Markovic BM, Markovic ZM, Milonjic SK, Trajkovic VS. 2009. Opposite effects of nanocrystalline fullerene (C(60)) on tumour cell growth in vitro and in vivo and a possible role of immunosuppression in the cancer-promoting activity of C(60). Biomaterials 30: 6940-6946.